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As major components of neuronal membranes, omega-3 polyunsaturated acids (n-3
PUFA) exhibit a wide range of regulatory functions, modulating from synaptic plasticity
to neuroinflammation, from oxidative stress to neuroprotection. Recent human and
animal studies indicated the n-3 PUFA neuroprotective properties in aging, with a clear
negative correlation between n-3 PUFA levels and hippocampal deficits. The present
multidimensional study was aimed at associating cognition, hippocampal neurogenesis,
volume, neurodegeneration and metabolic correlates to verify n-3 PUFA neuroprotective
effects in aging. To this aim 19 month-old mice were given n-3 PUFA mixture, or
olive oil or no dietary supplement for 8 weeks during which hippocampal-dependent
mnesic functions were tested. At the end of behavioral testing morphological and
metabolic correlates were analyzed. n-3 PUFA supplemented aged mice exhibited better
object recognition memory, spatial and localizatory memory, and aversive response
retention, without modifications in anxiety levels in comparison to controls. These
improved hippocampal cognitive functions occurred in the context of an enhanced cellular
plasticity and a reduced neurodegeneration. In fact, n-3 PUFA supplementation increased
hippocampal neurogenesis and dendritic arborization of newborn neurons, volume,
neuronal density and microglial cell number, while it decreased apoptosis, astrocytosis
and lipofuscin accumulation in the hippocampus. The increased levels of some metabolic
correlates (blood Acetyl-L-Carnitine and brain n-3 PUFA concentrations) found in n-3 PUFA
supplemented mice also pointed toward an effective neuroprotection. On the basis of the
present results n-3 PUFA supplementation appears to be a useful tool in health promotion
and cognitive decline prevention during aging.
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INTRODUCTION
The rise of life expectancy has amplified the interest in the preven-
tion and improvement of age-related brain dysfunctions. In fact,
cognitive deficits are hallmarks not only of pathological aging, as
occurring in Alzheimer’s disease and vascular dementia, but also
of non-pathological aging processes (Kobayashi et al., 2010). Age-
related cognitive decline is due to a progressive impairment of the
underlying brain cell processes due to neuroinflammation, oxida-
tive stress, reduced synaptic plasticity and neurogenesis, thus
leading to a consequent and irreversible neuronal loss of gray and
white matter volume (Driscoll et al., 2006; Masliah et al., 2006;
Brown, 2009). As recently advanced, some of these neurodegener-
ative processes may be influenced by a targeted diet (Denis et al.,
2013; Maruszak et al., 2014). Nutritional research indicates that
Western diets do not provide the aged brain with an optimal sup-
ply of omega-3 polyunsaturated fatty acids (n-3 PUFA) (Woo,
2011). In fact, aging is associated to reduced cerebral n-3 PUFA
levels due to reduced absorption, reduced n-3 PUFA capacity to
cross the blood-brain barrier, reduced capacity to convert shorter
chained fatty acids to longer fatty acids, and increased oxidative
stress (Yehuda, 2012).
Although epidemiological studies suggested that high n-3
PUFA dietary intake slows the age-related cognitive decline
(Fotuhi et al., 2009; Solfrizzi et al., 2010; Karr et al., 2011;
Denis et al., 2013), confounding factors, as socio-economical
status or healthy habits, make it difficult to isolate the specific
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protective impact of n-3 PUFA-enriched diet on cognitive func-
tion (Denis et al., 2013). Actually, the n-3 PUFA action in prevent-
ing age-related cognitive decline has been usefully addressed by
using animal models that offer better possibilities of controlling
over confounding factors and dietary manipulations (Luchtman
and Song, 2013). Namely, in rodents n-3 PUFA deficiency may
be associated with memory deficits and hippocampal plastic-
ity reduction, while n-3 PUFA supplementation may improve
learning and memory abilities, and neurogenic and synaptogenic
functions (Fedorova and Salem, 2006; Hooijmans et al., 2012;
Denis et al., 2013; Luchtman and Song, 2013).
Within the sparse literature on the cognitive enhancement
by n-3 PUFA in aging, no study has definitively detailed the
associations among cognition, hippocampal neurogenesis and
volumes, and metabolic correlates in the same non-pathological
aged animals. Thus, we investigated whether n-3 PUFA sup-
plementation in aged mice was able to counteract or at least
mitigate age-related cognitive decline and neurodegenerative pro-
cesses, to enhance hippocampal neurogenesis, volume and neu-
ronal density, and to ameliorate metabolic functions and lipid
membrane composition. To this aim aged mice were given n-
3 PUFA mixture, or olive oil or no dietary supplement for 8
weeks during which learning and memory abilities were inves-
tigated by means of a battery of behavioral tests assessing dif-
ferent facets of hippocampal-dependent functions. n-3 PUFA
supplementation effects on hippocampal neurogenesis, volume,
neuronal density, glial reactivity, and lipofuscin accumulation
were analyzed. Amino acids and carnitines levels in the periph-
eral blood, as well as brain lipid concentrations were also
measured.
MATERIALS AND METHODS
ANIMALS
Male aged C57B6/J mice (19 month-old at the onset of study;
33.7 ± 0.3 g) were used in the present research (Charles River
Laboratories, Italy). The animals were group-housed (three-four
mice/cage) with temperature (22–23◦C) and humidity controlled
(60 ± 5%), under a 12:12 h light/dark cycle with free access
to food and water. Animals were divided in three groups: (1)
mice supplemented with an n-3 PUFA mixture (440mg/kg) by
daily gavage for 8 weeks (5 day/week) (Group name: n-3 PUFA;
n = 12); (2) mice supplemented with olive oil (440mg/kg) by
daily gavage for the same period used as controls of an iso-caloric
intake, as reported in previous studies (Kotani et al., 2006; Oarada
et al., 2008; Nakamoto et al., 2010; Sinn et al., 2010; Danthiir et al.,
2011; Vinot et al., 2011) (Group name: OLIVE OIL; n = 13); (3)
no supplemented mice used as controls of eventual forced feed-
ing effects (Group name: NAÏVE; n = 12) (Figure 1). Animals’
weight was recorded weekly throughout the study. No signifi-
cant differences among groups were found during the 8 treatment
weeks [ANOVA (group×week): group: F(2, 34) = 2.92, p = 0.07;
week: F(7, 238) = 2.53, p = 0.01; interaction: F(14, 238) = 0.62,
p = 0.85]. All efforts weremade tominimize animal suffering and
to reduce their number in accordance with the European Union
Directive of September 22, 2010 (2010/63/EU). All procedures
were approved by the Italian Ministry of Health.
FOOD SUPPLEMENTS
Food supplementation was performed by daily gavage to ensure
that all cagemates received the same controlled amount of dietary
supplements regardless of social hierarchy or appetitive drive.
n-3 PUFA group was supplemented with a mixture of fatty
acids (Pfizer, Italy) containing high levels of n-3 PUFA, espe-
cially eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA)
and docosapentaenoic acid (DPA) (Table 1). OLIVE OIL group
was supplemented with olive oil (Trasimeno, Italy) (Table 1). The
three groups of animals were fed ad libitum with standard food
pellets (Mucedola 4RF21 standard diet GLP complete feed for
mice and rats; Mucedola, Italy) (Table 1).
EXPERIMENTAL PROCEDURES
After 4 weeks of dietary supplementation, mice were tested
in the following validated behavioral tasks tapping distinct
hippocampal-dependent abilities: Spatial Y-Maze (SYM) to assess
spatial memory; Morris Water Maze (MWM) to evaluate short-
and long-term localizatory memory; Object Recognition Test
(ORT) to analyze novelty recognition memory; and lastly
Contextual Fear Conditioning (CFC), to assess aversive associa-
tive learning. Furthermore, mice were tested in the Elevated Plus
Maze (EPM) to measure anxiety levels.
FIGURE 1 | Global timing of the experimental procedure.
Experimental groups of aged mice (n-3 PUFA, OLIVE OIL, and
NAÏVE), type of dietary supplementation (duration: 8 weeks),
behavioral testing (EPM, Elevated Plus Maze; SYM, Spatial Y-Maze;
MWM, Morris Water Maze; ORT, Object Recognition Maze; CFC,
Contextual Fear Conditioning), morphological analyses (hippocampal
volumes, cell density, caspase-3 levels, astroglia and microglial cells,
lipofuscin concentrations, neurogenesis) and metabolic correlates
(blood amino acids and carnitines levels; brain n-3 PUFA levels) are
indicated.
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Table 1 | Fatty acid composition of the dietary supplements (n-3
PUFA, olive oil) and standard diet.
Fatty acids Percentage
n-3 PUFA MIXTURE
SFA 2.4
MUFA 8.0
PUFA 89.6
Of which n-3 PUFA:
EPA
82.5
51.8
DHA 21.2
DPA 3.3
SDA 2.4
ETA 1.4
HPA 1.2
ALA 1.2
OLIVE OIL
SFA 15.0
MUFA 75.0
PUFA* 10.0
Of which n-3 PUFA:
ALA
1.0
1.0
Nutrients Percentage
STANDARD DIET
Cereals 66.5
Animal proteins 3.5
Vegetable proteins 18.2
Amino acids 0.1
Fodders 7.5
Vitamin and mineral mixtures 3.2
Fatty acids 0.4
Of which SFA 21.3
MUFA 22.0
PUFA* 56.7
Of which n-3 PUFA:
ALA
8.6
8.6
other nutrients 0.6
The fish-oil-based n-3 PUFA mixture contains mostly (≈83%) n-3 PUFA (EPA,
eicosapentaenoic acid, 20:5 n-3; DHA, docosahexaenoic acid, 22:6 n-3; DPA,
docosapentaenoic acid, 22:5 n-3; SDA, stearidonic acid, 18:4 n-3; ETA, eicosate-
traenoic acid, 20:4 n-3; HPA, heneicosapentaenoic acid, 21:5; n-3 ALA, α-
linolenic acid, 18:3 n-3) and low levels of MUFA. The n-3 PUFA mixture dose
corresponds to ≈360 mg/kg of n-3 PUFA (Calviello et al., 1997). Conversely, olive
oil contains mostly MUFA and has low levels of n-3 PUFA (1%). *Indicates
no presence of EPA, DHA and DPA. Abbreviations: SFA, saturated fatty acids;
MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.
After behavioral testing, a sample of 4 mice of each group
received intraperitoneal (i.p.) BrdU injections daily for 6 days.
Other 5 animals of each group were used to collect peripheral
blood from the tail. At the end of these procedures, the animals
were transcardially perfused and their brains were removed and
cryopreserved at −80◦C to perform immunocytochemistry and
metabolic analyses.
BEHAVIORAL TESTING
Elevated Plus Maze (EPM)
The maze was formed by a wooden structure in the shape of
a cross with a central platform and four 35 × 6 cm arms raised
100 cm above the ground. The north and south arms were open,
the east and west arms were enclosed by walls 20 cm high. During
a 5-min trial the mouse was placed in the central platform and
allowed to freely explore the maze. Since mice avoid open areas
by confining movements to enclosed spaces or to the edges of a
bounded space, a typical mouse tends to spend the majority of
trial time in the closed arms. The entire apparatus was cleaned
after each trial to remove olfactory cues. Trials were recorded
by a ceiling-mounted camera and analyzed by a video analyzer
(Ethovision XT, Noldus, The Netherlands). To evaluate anxiety
level the following EPM parameters were measured: total entries
and total time spent in the open and closed arms, defecations
(Ruehle et al., 2013).
Spatial Y-Maze test (SYM)
The Y-maze apparatus made of gray Plexiglas consisted of three
identical arms (8 × 30 × 15 cm) with a 120◦ angle between adja-
cent arms. The three arms were designated as: start arm (always
open), in which the mouse started to explore the maze; familiar
arm (always open); novel arm, blocked during the first trial and
opened during the second trial (Ma et al., 2007). Several visual
cues were placed on the inner walls of the maze. Y-maze test was
performed in a dimly lighted room and consisted of two trials
separated by a 1 h inter-trial interval (ITI). During the first trial
(training phase) lasting 10min the mouse was allowed to explore
two arms (the start arm and familiar arm) with the novel arm
being blocked. During the second trial (retention phase) lasting
5min the three arms were opened and the mouse placed in the
start arm was allowed to freely explore all three arms. Maze floor
and walls were cleaned after each trial to remove olfactory cues.
Trials were recorded by a ceiling-mounted camera and analyzed
by a video analyzer (Ethovision XT, Noldus, The Netherlands).
To evaluate the preference for the novel arm (novelty) the fol-
lowing parameters of retention phase were analyzed: first entry in
the novel arm, total entries, total distances and time spent in the
familiar vs. novel arm.
Morris Water Maze (MWM)
The mouse was placed in a circular white pool (diameter 140 cm)
filled with 24◦C water made opaque by the addition of atoxic
acrylic white color (Giotto, Italy) (Carrié et al., 2002). An escape
platform (diameter 5 cm) with a rough surface was placed in the
middle of the NW quadrant 20 cm from the side walls. It was
submerged 0.5 cm the water level. The pool located in a room
uniformly lighted by four lamps (25 W each) was surrounded by
several extra-maze cues. The water maze was surmounted by a
video camera whose signal was relayed to a monitor and to the
image analyzer (Ethovision XT, Noldus, The Netherlands). The
protocol consisted of two phases. During the Place phase, mice
were submitted to five consecutive sessions of three 60 s-trials,
with 30 s-ITI for a total of 15 trials. Inter-session interval was
15min during which mice were put in their home cages. At
the beginning of each trial, mice were gently released into the
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water from pseudo-randomly varied starting points and were
allowed to swim around to find the hidden platform. Mice
that did not locate the platform within 60 s, were guided there
by the experimenter. After the animals climbed to the plat-
form, they were allowed to remain on it for 30 s. After 24 h,
mice were submitted to the Probe phase, in which the plat-
form was removed and the mice were allowed to search for it
for 30 s.
To evaluate localizatorymemory the followingMWMparame-
ters were analyzed: latency to reach the platform, mean swimming
velocity, percentage of time spent in each of the four quadrants
during Probe phase.
Object Recognition Task (ORT)
The apparatus consisted in a parallelepiped chamber made of
transparent Plexiglas (56 × 42 × 21 cm). The task consisted of
three trials, habituation, pre-test and test (De Bruin and Pouzet,
2006; Arsenault et al., 2011). During habituation, mice were
introduced in the empty chamber and left to freely explore it
for 10min. Afterwards, they were put in their home cages for
5min during which two identical objects (A1 and A2: 8 cm-
diameter white Plexiglas disk vertically fixed to a white rectan-
gular base) were placed in the chamber. During the pre-test,
mice were allowed exploring the objects for 5min. After a 1 h-
ITI, animals were placed again for 5min in the chamber, where
one of the original objects was replaced by a novel one (B:
8 cm-diameter gray plastic sphere mounted on a squared trans-
parent base). A video camera connected to a monitor and to
the image analyzer (Ethovision XT, Noldus, The Netherlands)
was placed on top of the apparatus. To evaluate the spon-
taneous tendency to contact the novel object (novelty) the
following ORT parameters were analyzed: contact time with
objects, distance traveled in the arena, mean velocity, rearings,
grooming, defecations. A discrimination index was calculated:
contact time with the novel object (Tno) minus contact time
with the familiar one (Tfo)/total contact time with objects,
Tno−Tfo
Tno+Tfo .
Contextual Fear Conditioning (CFC)
The apparatus consisted of a conditioning chamber (49 × 21 ×
21 cm; Mod. 7532, Ugo Basile, Italy) with walls made of gray
Plexiglas and ceiling made of transparent Plexiglas to allow video-
recording. The grid-floor (steels spaced by 1.5 cm) was connected
to a shock generator scrambler (conditioner 7531, Ugo Basile,
Italy) (Cutuli et al., 2013).
CFC encompassed three sessions: baseline, training and
context test. After a 3-min acclimation to the conditioning
apparatus (baseline), the mouse received three foot-shocks
(0.5mA; 2 s) delivered with 60 s-ITI (training). After 24 h,
it was placed again in the chamber for 6min receiving no
foot-shock (context test) (Crawley, 1999). Animals’ behavior
was recorded by a ceiling-mounted video camera and then
analyzed through an image analyzer (Ethovision XT, Noldus,
The Netherlands). To evaluate aversive learning the following
CFC parameters were analyzed: freezing duration (considered as
behavioral immobility, except for respiration movements) and
defecations.
MORPHOLOGICAL ANALYSES
BrdU treatment and immunocytochemistry
Four mice per group received daily i.p. injections of BrdU at a
dose of 50mg/kg BrdU dissolved in saline (0.9% NaCl adjusted to
pH 7.2 with NaOH) for 6 days. One day after the final injection
the animals were sacrificed and transcardially perfused, under
deep anesthesia with chloral hydrate with 4% paraformalde-
hyde in 0.1M phosphate buffer (PBS). The brains were removed
and kept overnight in 4% paraformaldehyde (PFA). Afterwards,
brains were equilibrated in 30% sucrose and cryopreserved
at −80◦C.
The hippocampus from brains embedded in Tissue-Tek
OCT (Sakura, USA) was cut by cryostat at −25◦C in 40μm
coronal serial free-floating sections. To perform BrdU detection,
DNA was denaturated with 2N HCl for 40min at 37◦C to
facilitate antibody access, followed by 0.1M borate buffer pH
8.5 for 20min. Sections were incubated overnight at 4◦C with a
primary antibody rat anti-BrdU (AbD Serotec Cat# MCA2060
RRID:AB_323427) diluted 1:300 in TBS containing 0.1% Triton,
0.1% Tween 20 and 3% normal donkey serum (blocking solu-
tion). For immunofluorescence analysis, sections were then
stained for multiple labeling by using fluorescent methods. After
permeabilization with 0.3% Triton X-100 in PBS, the sections
were incubated with 3% normal donkey serum in PBS for 16–18 h
with the following primary antibodies: 1:200 goat polyclonal anti-
bodies against Doublecortin (DCX) (Santa Cruz Biotechnology,
Inc. Cat# sc-8066 RRID:AB_2088494), 1:300 rabbit polyclonal
antibodies against Glial Fibrillary Acidic Protein (Promega Cat#
G5601 RRID:AB_430855), 1:150 rabbit monoclonal antibody
against Ki67 (Lab Vision Cat# RM-9106-S RRID:AB_149707);
1:100 rabbit polyclonal antibody against Iba-1 (Wako Chemicals
USA, Inc. Cat# 019-19741 RRID:AB_839504), 1:100 goat
polyclonal antibody against Iba-1 (Abcam Cat# ab5076
RRID:AB_2224402); 1:100 rabbit polyclonal antibody against
cleaved Caspase-3 (Cell Signaling Technology Cat# 9661S
RRID:AB_331440). Secondary antibodies used to visualize the
antigen were 1:200 donkey anti-rat Cy3-conjugated (Jackson
ImmunoResearch; BrdU) 1:100, donkey anti-rabbit Cy2-
conjugated (Jackson ImmunoResearch; Ki67, Iba-1), 1:100 don-
key anti-goat Cy2-conjugated (Jackson ImmunoResearch Cat#
705-225-147 RRID:AB_2307341; DCX, Iba-1), 1:200 anti-rabbit
Cy3-conjugated (Jackson ImmunoResearch; GFAP, Caspase-3).
Images of the immunostained sections were obtained by laser
scanning confocal microscopy by using a TCS SP5 microscope
(Leica Microsystem; Germany).
Analyses were performed in sequential scanning mode to rule
out cross-bleeding between channels.
Quantification of cell numbers
Quantitative analysis of hippocampal cell populations was per-
formed by means of design-based (assumption-free, unbiased)
stereology. Slices were collected using systematic random sam-
pling. The brain was coronally sliced in rostro-caudal direction,
thus including the entire hippocampus. Approximately 40 coro-
nal sections of 40μm were obtained from each brain; about
1-in-6 series of sections (each slice thus spaced 240μmapart from
the next) were analyzed by confocal microscopy and (by unbiased
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stereological method) used to count the number of cells express-
ing the indicated markers throughout the rostro-caudal extent of
the whole hippocampus. The total estimated number of cells pos-
itive for each of the indicated markers within the dentate gyrus
(DG), CA1 and CA3 areas was obtained by multiplying the aver-
age number of positive cells per section by the total number of
40μm sections comprising the entire DG, CA1 and CA3 (spaced
240μm) (Jessberger et al., 2005; Kee et al., 2007; Farioli-Vecchioli
et al., 2008).
Cells with lipofuscin deposits were recognized by their char-
acteristic appearance and fluorescence of similar intensity in
all three channels investigated (Kempermann et al., 2002). We
counted only heavily loaded cells, in which the deposits obscured
more than half of the nucleus.
An investigator blind to the experimental specimen performed
cell count and proportional analyses. Cell number quantification
was performed in at least 3 animals per group.
Volumetric measurements
Volumes of the DG, Ammon horn CA1 and CA3 and whole
hippocampus were estimated by quantitative light microscopy
using the Cavalieri’s method (Pakkenberg and Gundersen, 1997).
In brief, rostro-caudal sections from hippocampus of each ani-
mal (taking every sixth serial section) were mounted onto glass
slide and stained with 4′,6-diamidino-2-phenylindole (DAPI) for
1min. Stained sections were viewed at low magnification using
Olympus BX53 digital photomicroscope. Digital images were
then captured electronically and displayed on a computer screen.
For each animal, DG, Ammon horn and whole hippocampus
volumes were subsequently derived by multiplying the calcu-
lated mean surface area by the section thickness (40μm) and the
total actual number of sections in which the hippocampus was
present.
Neuronal density measurements
Areal neuronal density values (number of neurons/mm2) were
calculated within each of the hippocampal subfields (DG, CA3,
and CA1) in the same tissue sections (stained with DAPI) that
underwent the quantitative image analysis described elsewhere
(Tandrup, 2004). Cells were counted within a rectangular area
on a computer monitor, ranging in size from 1989μm2 (60 ×
35.15μm) to 2270μm2 (58.4 × 38.9μm), and the rectangular
area was superimposed onto the pyramidal cells of CA1 and CA3
areas and onto the granule cells of DG. The results were expressed
as the cell density per mm2.
Dendritic growth of DCX+ neurons
Dendritic analysis of DCX+ neurons was performed by acquiring
z-series of 15–25 optical sections at 1–1.5 lm of interval with a 40X
oil lens, with the confocal system TCS SP5 (Leica Microsystem).
Two-dimensional projections at maximum intensity of each z-
series were generated with the LAS AF software platform (Leica
Microsystem) in the TIFF format, and files were imported in
the I.A.S. software (Delta Systems) to measure dendritic length.
The number of branching points was counted manually in the
same images. For each data point, 20–30 cells from 3 mice were
analyzed (Farioli-Vecchioli et al., 2008).
METABOLIC CORRELATES
Analysis of amino acids and carnitines by direct infusion Mass
Spectrometry (DIMS)
Whole blood taken from the tail was collected on filter paper
as dried blood spot (DBS), which is particularly suitable for
small volume samples. The determination of amino acids
(proline, valine, leucine/isoleucine/hydroxyproline, ornithine,
methionine, phenylalanine, arginine, citrulline, tyrosine, glycine,
alanine, serine, threonine, asparagine, aspartate, lysine/glicine,
glutamate, histidine) and carnitines (free carnitine, acetylcarni-
tine, propionylcarnitine, butyrylcarnitine, isovalerylcarnitine,
3-hydroxybutyrylcarnitine/malonylcarnitine, 3-hydroxyisoval
erylcarnitine/methylmalonylcarnitine, glutarylcarnitine/3-
hydroxyhexanoylcarnitine, adipylcarnitine, tetra-decenoy
lcarnitine, myristoylcarnitine, hexadecenoylcarnitine, palmitoy
lcarnitine, linoleylcarnitine, oleylcarnitine, stearoylcarnitine) was
performed on filter paper card DBS samples by direct infusion
mass spectrometry (DIMS) following a standardized high-
throughput screening method as described elsewhere (Chace
et al., 2002; Rossi et al., 2011). The analysis was performed in DBS
samples by adding isotopically labeled internal standards, accord-
ing to the principle of isotope dilution internal standardization.
Briefly, filter paper disks containing approximately 3–3.2μL of
whole blood, were punched out from DBS samples and from
the quality controls (QCs) using an automatic puncher, into a
polypropylene microliter plate. 100μL of the extraction solution
containing the internal standards were added to each paper disk,
and the plate was shaken in a thermo mixer (700 rpm, 45◦C,
50min). The internal standards as well as the extraction solution
and the QCs were from the NeoBase Non-derivatized MSMS Kit
(Perkin Elmer Life and Analytical Sciences, Finland) (Ostrup and
Wallac, 1994; Food and Drug Administration, 2004). 75μL from
the content of each well were transferred to a new microliter
plate. The plate was placed in the autosampler for analysis. Low
and high blood spot QCs were run in replicate in each plate,
before and after the real samples. The DIMS analysis for the
evaluation of metabolite profile in DBS samples was performed
using a Liquid Chromatography-tandem Mass Spectrometry
(LC/MS/MS) system consisting of an Alliance HT 2795 HPLC
Separation Module coupled to a Quattro Ultima Pt ESI tandem
quadrupole mass spectrometer (Waters Corporation, USA)
(Sirolli et al., 2012; Bonomini et al., 2013; Rizza et al., 2014).
The instrument was operated in positive electrospray ionization
mode, using MassLynx V4.0 Software (Waters) with auto data
processing by NeoLynx (Waters Corporation, USA). The 30μL
injections were made directly into the ion source through a
narrow peek tube with a total run time (injection-to-injection)
of 1.8min. The mass spectrometer ionization source settings
were optimized for maximum ion yields for every analyte. The
capillary voltage was set to 3.25 kV, the source and desolvation
temperature were 120◦C and 350◦C respectively, and the collision
cell gas pressure was 3–3.5 e-3 mbar Argon (Sirolli et al., 2012;
Bonomini et al., 2013; Rizza et al., 2014).
Analysis of fatty acids by GC/MS
Fatty acids were extracted using the method reported by Folch
(Folch et al., 1957) with slight modifications. Briefly, brains were
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homogenized in CHCl3/MeOH (2:1 v/v) to a final dilution of
20-fold of the original sample volume, assuming that the tis-
sue has the same specific gravity of water. Heptadecanoic acid
was used as internal standard. The resulting organic phase was
evaporated to dryness in a speed-vac at room temperature and
then derivatized with BSTFA-TMCS 99:1 v/v (Sigma-Aldrich,
Italy) for 1 h at 60◦C. Derivatized samples were transferred
in the injection vial and added with 20% v/v of Acetone.
GC/MS analyses were performed using a Focus GC (Thermo
Scientific, USA) equipped with 30m × 0.25mm fused sil-
ica capillary column SLB™-5MS (Supelco) and connected to
a PolarisQ mass spectrometer (Thermo Scientific, USA). 2μL
of samples were injected in split mode (1:10 ratio), the injec-
tor temperature was set at 200◦C; the carrier gas was Helium
and the flow rate was maintained constant at 1ml/min. The
initial oven temperature of 100◦C was held for 1min and
then raised to 250◦ C at 10◦C/min and maintained for 6min.
After then the oven temperature was increased up to 310◦C
at 20◦C/min and held for 5min. Mass transfer line was
maintained at 280◦C and the ion source at 200◦C. Analyses
were performed in Selected Ion Monitoring (SIM) mode and
fatty acids were identified by comparison with commercial
standards.
Statistical analyses
All data were tested for normality (Shapiro-Wilk’s test) and
homoscedasticity (Levene’s test) and presented as mean ± s.e.m.
Behavioral data and metabolic correlates were analyzed by using
one- and Two-Way ANOVAs (with group as between-factor and
arm/session/quadrant as within-factor) followed by Newman-
Keuls’s tests. When parametric assumptions were not fully met,
non-parametric analyses of variance (χ2 and Mann-Whitney U-
tests) were used. Morphological data were analyzed by using
Student’s T-test. Values of p < 0.05 were considered significant
(Statistica 7, Statsoft).
RESULTS
BEHAVIORAL TESTING
Elevated Plus Maze (EPM)
As indicated by One-Way ANOVAs on entry frequencies
[F(2, 34) = 0.41, p = 0.67], time spent in the close vs. open
arms [F(2, 34) = 3.08, p = 0.06] and defecations [F(2, 34) = 1.02,
p = 0.37], the anxiety levels resulted similar for the three experi-
mental groups, regardless of the food supplementation type.
Spatial Y-Maze (SYM)
When allowed to choose between the novel and familiar arm,
n-3 PUFA mice showed better discrimination abilities of spatial
novelty as indicated by the higher number of animals first enter-
ing the novel arm and by the total entries in the novel arm. No
motivational differences were observed among groups, given their
similar total entries. Namely, analyses on frequency of first entry
in the novel arm revealed that only n-3 PUFA mice showed a sig-
nificant preference for it (χ21 = 8.33, p = 0.004), while OLIVE
OIL (χ21 = 0.07, p = 0.78) and naïve (χ21 = 0.69, p = 0.41) mice
chose an arm by chance (Figure 2A). A Two-Way ANOVA (group
x arm) on total entries revealed significant arm effect [F(1, 35) =
32.05, p < 0.0001] and interaction [F(2, 35) = 4.82, p = 0.01],
while group effect was not significant [F(2, 35) = 0.14, p = 0.87].
Post-hoc comparisons on interaction demonstrated that only n-
3 PUFA group entered more the novel arm (p = 0.0001), while
OLIVE OIL (p = 0.13) and NAÏVE (p = 0.09) groups equally
entered the novel and the familiar arm (Figure 2B). No signif-
icant differences among groups were found on time spent in
each arm [group: F(2, 35) = 2.79, p = 0.07; arm: F(1, 35) = 0.44,
p = 0.51; interaction: F(2, 35) = 2.56, p = 0.09] and total dis-
tances [group: F(2, 35) = 1.04, p = 0.36; arm: F(1, 35) = 11.07,
p = 0.002; interaction: F(2, 35) = 2.43, p = 0.10].
Morris Water Maze (MWM)
Regardless of the experimental conditions, all mice learned to
localize the hidden platform as the Place sessions went by, as
revealed by a Two-Way ANOVA (group × session) on latency val-
ues [group: F(2, 34) = 2.68, p = 0.08; session: F(4, 136) = 10.76,
p < 0.0001; interaction: F(8, 136) = 0.94, p = 0.49] (Figure 2C).
Furthermore, no differences in mean swimming velocity among
groups were found [F(2, 34) = 0.28, p = 0.76]. A Two-Way
ANOVA (group× quadrant) performed on time spent in the four
quadrants during the Probe trial (24 h after Place phase) revealed
significant quadrant effect [F(3, 102) = 11.05, p < 0.0001] and
interaction [F(6, 102) = 7.07, p < 0.0001], while group effect
[F(2, 34) = 0.26, p = 0.77] was not significant. Interestingly, post-
hoc comparisons revealed that only n-3 PUFA group swam sig-
nificantly longer in the quadrant previously rewarded by the
presence of the platform (n-3 PUFA vs. OLIVE OIL: p = 0.01; n-
3 PUFA vs. NAÏVE: p = 0.001; OLIVE OIL vs. NAÏVE: p = 0.15)
(Figure 2D). Time spent in the previously rewarded quadrant was
significantly higher than the time spent in the other quadrants
only in n-3 PUFA group (always p < 0.001).
Object Recognition Task (ORT)
As indicated by the discrimination index (Figure 2E), n-3 PUFA
group better recognized object novelty in comparison to both
NAÏVE (Mann-Whitney U, Z = −2.40, p = 0.01) and OLIVE
OIL (Mann-Whitney U, Z = −2.81, p = 0.004) groups. No sig-
nificant differences among groups were found in emotional
(grooming and defecations) as well as in explorative (distance,
velocity and rearing) indices.
Contextual Fear Conditioning (CFC)
n-3 PUFA supplementation enhanced associative memory
between aversive stimulus and environmental context, as indi-
cated by the higher freezing behavior of n-3 PUFA group, a
readout of increased memory. Namely, a Two-Way ANOVA
(group × session) on freezing duration revealed significant group
[F(2, 34) = 6.93, p = 0.003] and session [F(2, 68) = 191.07, p <
0.0001] effects. Also the interaction [F(2, 68) = 3.39, p = 0.01]
was significant. Post-hoc comparisons on interaction revealed
that while during baseline and training all animals exhibited
similar freezing levels, during context test n-3 PUFA group exhib-
ited significantly higher freezing levels in comparison to OLIVE
OIL (p = 0.02) and NAÏVE (p = 0.0001) groups (Figure 2F).
Defecations did not differ among groups throughout the test
[F(2, 34) = 0.69, p = 0.51].
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FIGURE 2 | n-3 PUFA effects on behavioral performances. (A,B) First entry
(A) and total entries (B) in the familiar (F) and novel (N) arm displayed by the
three experimental groups in Spatial Y-Maze (SYM). (C,D) Mean escape
latency to reach the hidden platform during Place phase of Morris Water
Maze (MWM) (C) and time spent in the rewarded quadrant during Probe trial
(D). (E) Discrimination index in Object Recognition Test (ORT). (F) Mean
freezing time exhibited during Baseline, Training (Inter-Trial Intervals: ITI) and
Context Test of Contextual Fear Conditioning (CFC). Asterisks inside the
graphs indicate the significance of comparisons between groups: ∗p < 0.05,
∗∗p ≤ 0.01, or ∗∗∗p ≤ 0.001.
MORPHOLOGICAL ANALYSES
Hippocampal volume and neuronal density
n-3 PUFA mice showed a total hippocampal volume significantly
increased in comparison to OLIVE OIL (p = 0.03) and NAÏVE
(p = 0.04) groups (Figure 3). To thoroughly analyze n-3 PUFA
effect on hippocampal subfields, the volumes of Ammon Horn
(CA = CA1 + CA3) and dentate gyrus (DG) were measured.
In n-3 PUFA group CA volume significantly increased in com-
parison to OLIVE OIL (p = 0.0004) and NAÏVE (p = 0.0004)
groups. Even in DG n-3 PUFA group exhibited enhanced volume
in comparison to OLIVE OIL (p = 0.04) and NAÏVE (p = 0.04)
groups.
To evaluate whether the volumetric differences were related to
changes in neuronal density DAPI-stained nuclei were counted
in DG, CA3, and CA1 hippocampal subfields (Figure 3). In DG
n-3 PUFA supplementation resulted in a significant increase of
granule cell density in comparison toOLIVEOIL (p = 0.005) and
NAÏVE (p = 0.0001) groups. Even in CA3 pyramidal neuron den-
sity significantly increased in n-3 PUFA group in comparison to
OLIVE OIL (p = 0.03) and NAÏVE (p = 0.03) groups. Finally, in
CA1 n-3 PUFA group showed a significant increment in the pyra-
midal neuron density in comparison to OLIVE OIL (p = 0.0007)
and NAÏVE (p = 0.0008) groups. All together, these data indi-
cate that the n-3 PUFA-induced increase of hippocampal volumes
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FIGURE 3 | n-3 PUFA effects on hippocampal volumes and cell density.
Volumes of whole hippocampus, Ammon Horn (CA1+CA3) and Dentate
Gyrus resulted significantly enhanced in n-3 PUFA group in comparison to
NAÏVE and OLIVE OIL groups. Also cell density was significantly increased in
Dentate Gyrus, CA3 and CA1 of n-3 PUFA group in comparison to both
control groups. ∗p < 0.05, ∗∗p < 0.01, or ∗∗∗p < 0.001; Student’s T test.
was due to a decreased neuronal loss, as revealed by the increased
neuronal density observed in the n-3 PUFA-treated aged mice.
Hippocampal apoptotic cell death
To verify whether the increased cell density observed in n-3
PUFA group was linked to a decrease of apoptotic cell death,
the apoptotic marker activated caspase-3 was measured in DG,
CA1, and CA3. The number of caspase-3+ cells was very low in
the three hippocampal subfields, without any difference among
groups. By contrast, several caspase-3+ cellular debris were scat-
tered throughout DG, CA1 and especially CA3 subfields in all
groups, with a marked reduction was observed in n-3 PUFA
group (Figure 4A).
Hippocampal microglia
Microglial cells are responsible for maintaining the extracellular
environment of the brain, by regulating uptake and degradation
of non-functional or apoptotic material. Reduced microglia self-
renewal capacity and impaired clearance functions are reported
in aging (Sierra et al., 2010; Gemma and Bachstetter, 2013). n-
3 PUFA group displayed a significant increase in the number of
microglial Iba1+ cells in comparison to both control groups in
DG (n-3 PUFA vs. OLIVE OIL: p = 0.01; n-3 PUFA vs. NAÏVE:
p = 0.0007), in CA3 (n-3 PUFA vs. OLIVE OIL: p < 0.0001; n-3
PUFA vs. NAÏVE: p = 0.0002), and in CA1 (n-3 PUFA vs. OLIVE
OIL: p = 0.03; n-3 PUFA vs. NAÏVE: p = 0.007) (Figure 4A).
More specifically, we observed in n-3 PUFA group an increase
of the microglial cells phagocytosing apoptotic caspase-3+ neu-
ronal debris in DG (n-3 PUFA vs. OLIVE OIL: p = 0.03; n-3
PUFA vs. NAÏVE: p = 0.04) and CA1 (n-3 PUFA vs. OLIVE
OIL: p = 0.03; n-3 PUFA vs. NAÏVE: p = 0.01) when compared
with the other experimental group (Supplementary Figure 1
and Figure 4A, square boxes). These results suggest that n-3
PUFA supplementation increases the phagocytosing microglial
population, likely providing a protective mechanism during
aging.
Hippocampal astroglia reactivity
A typical biomarker of the aging brain is the astrocyte hyper-
trophy with increased GFAP expression (Salminen et al., 2011).
In n-3 PUFA group, GFAP immunoreactivity was significantly
reduced in comparison to both control groups in DG (n-3 PUFA
vs. OLIVE OIL: p = 0.0002; n-3 PUFA vs. NAÏVE: p = 0.0002)
and CA3 (n-3 PUFA vs. OLIVE OIL: p = 0.002; n-3 PUFA
vs. NAÏVE: p = 0.001), but not in CA1 (n-3 PUFA vs. OLIVE
OIL: p = 0.43; n-3 PUFA vs. NAÏVE: p = 0.70) (Figure 4B).
These results indicate that n-3 PUFA supplementation markedly
reduced astrocytosis.
Hippocampal lipofuscin deposits
The non-specific lipofuscin deposits in neurons are a promi-
nent sign of aging and their low levels are considered a measure
of “cellular health” (Kempermann et al., 2002). In n-3 PUFA
group the number of lipofuscin autofluorescent cells was signif-
icantly reduced in all hippocampal subfields in comparison to
both control groups (DG: n-3 PUFA vs. OLIVE OIL: p = 0.04;
n-3 PUFA vs. NAÏVE: p = 0.01; CA3: n-3 PUFA vs. OLIVE OIL:
p = 0.009; n-3 PUFA vs. NAÏVE: p = 0.0009; CA1: n-3 PUFA
vs. OLIVE OIL: p = 0.0006; n-3 PUFA vs. NAÏVE: p = 0.0007)
(Figure 4C). These data indicate that n-3 PUFA supplementation
resulted in ameliorated neuronal status promoting a decreased
cellular degeneration and consequent neuronal loss.
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FIGURE 4 | n-3 PUFA effects on hippocampal glial populations and
lipofuscin deposits. (A) Representative fluorescence images of confocal
optical sections of Dentate Gyrus, CA3 and CA1 in NAÏVE and n-3 PUFA
groups, showing Iba-1+ (green, arrows) and caspase-3+ (red) cells. Scale
bar 50μm. In the central small panels, the higher magnifications (square
boxes) show the neuronal caspase-3+ debris (red, arrowheads)
phagocytated by the microglial cells (green, arrowheads). Scale bar 25μm.
The histograms on the right show the Iba1+ cell number of the Dentate
Gyrus, CA3 and CA1 in n-3 PUFA, NAÏVE and OLIVE OIL groups. (B)
Representative fluorescence images of confocal optical sections
representing GFAP+ cells (red) in Dentate Gyrus, CA3, and CA1 of NAÏVE
and n-3 PUFA groups, showing decreased astrocytosis in the n-3 PUFA
group in Dentate gyrus and CA3 but not in CA1. Scale bar 50μm. The
histograms on the right show the GFAP+ cell number of the Dentate
Gyrus, CA3, and CA1 in n-3 PUFA, NAÏVE, and OLIVE OIL groups. (C)
Representative fluorescence images of confocal optical sections
representing lipofuscin autofluorescent cells in the Dentate Gyrus of n-3
PUFA group (arrowhead). Scale bar 50μm. The bottom histograms show
quantitative analysis of the lipofuscin-loaded cells in Dentate Gyrus, CA3
and CA1. ∗p < 0.05, ∗∗p ≤ 0.01, or ∗∗∗p ≤ 0.001; Student’s T test.
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Hippocampal neurogenesis
Cell proliferation. The subgranular zone (SGZ) of the hippocam-
pal DG constitutes one of the two neurogenic niches of the adult
brain along with the subventricular zone (SVZ) (Eriksson et al.,
1998). In SGZ, newborn cells proliferate from neural stem cells
and give rise to immature neurons which migrate into the inner
part of granule cell layer, where they mature and integrate into
the pre-existing circuitry by receiving inputs from the entorhi-
nal cortex, and extending projections into the CA3 (Zainuddin
and Thuret, 2012). In order to evaluate the effect of n-PUFA
administration on the hippocampal neurogenesis of agedmice we
investigated the proliferation and differentiation of newborn neu-
rons in the three experimental groups. In the n-3 PUFA group the
number of BrdU+ cells was significantly increased in compari-
son to both control groups (n-3 PUFA vs. OLIVE OIL: p = 0.004;
n-3 PUFA vs. NAÏVE: p < 0.0001), while no significant difference
was evident between OLIVE OIL and NAÏVE groups (Figure 5A).
Similarly, a significantly higher number of Ki67+ cells (Scholzen
and Gerdes, 2000) was found in n-3 PUFA group compared to
both control groups (n-3 PUFA vs. OLIVE OIL: p < 0.0001; n-
3 PUFA vs. NAÏVE: p < 0.0001). The number of Ki67+ cells
found in OLIVE OIL and NAÏVE mice was not significantly dif-
ferent (Figure 5A). These data demonstrate that in the DG the
n-3 PUFA supplementation was effective in strongly increasing
the cellular proliferation rate of newly-generated neurons that was
conversely barely detectable in NAÏVE and OLIVE OIL mice.
Cell differentiation. In n-3 PUFA group an increased number
of DCX+ cells in the SGZ of DG was found in comparison
to OLIVE OIL (p = 0.001) and NAÏVE (p < 0.0001) groups,
while no statistical difference was found between OLIVE OIL and
NAÏVE groups (p = 0.48) (Figure 5A). To investigate whether n-
3 PUFA supplementation resulted in altered morphology of early-
differentiated DCX+ neuroblasts, in term of dendritic length
and branching points, two-dimensional projections of confocal
z-series obtained from DCX+ cells were analyzed. In n-3 PUFA
FIGURE 5 | n-3 PUFA effects on hippocampal neurogenesis. (A)
Representative images showing the increase of the Ki67+ cells in the
dentate gyrus of the mice treated with n-3 PUFA, when compared with
NAÏVE group. At higher magnification (square boxes) the presence of a
cluster of Ki67+ cells, which is a sign of intense proliferative activity can be
noted for the n-3 PUFA treated mice (right panel), but not for the NAÏVE mice
(left panel). Scale bars 50μm and 25μm. The histograms show the increase
of BrdU±, Ki67+ and DCX+ cells in the n-3 PUFA mice, when compared with
NAÏVE and OLIVE OIL mice. (B) Representative morphology of DCX cells,
analyzed from NAÏVE and n-3 PUFA experimental groups, showing an
increase of dendritic complexity in the n-3 PUFA neuronal progenitors. Scale
bar 50μm. Quantification of dendritic length and dendritic branching points
measured in NAÏVE, OLIVE OIL, and n-3 PUFA experimental groups.
∗∗p ≤ 0.01, or ∗∗∗p ≤ 0.001; Student’s T test.
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group a significant increase of dendritic length (n-3 PUFA vs.
OLIVE OIL: p = 0.001; n-3 PUFA vs. NAÏVE: p < 0.0001) and
branching points (n-3 PUFA vs. OLIVE OIL: p = 0.001; n-3
PUFA vs. NAÏVE: p < 0.0001) was observed (Figure 5B). These
data indicate that the n-3 PUFA supplementation significantly
stimulated neuroblast differentiation leading to major dendritic
complexity.
METABOLIC CORRELATES
Free amino acids and carnitines
Blood levels of amino acids and carnitines are reported in Table 2.
Supervised and Unsupervised Principal Component Analysis did
not reveal any significant difference among the experimental
groups. However, One-Way ANOVA on the acetylcarnitine (ALC)
levels revealed a significant difference [F(2, 12) = 5.52, p = 0.02]
among groups. Post-hoc comparisons indicated that ALC blood
levels were significantly higher in n-3 PUFA group in comparison
to OLIVE OIL (p = 0.03) and NAÏVE (p = 0.02) (Figure 6A).
No significant differences were found for amino acids blood
levels.
n-3 PUFA brain levels
EPA, DHA, and DPA were measured as the major n-3
PUFA components of brain cell membranes. Moreover, the
EPA+DHA+DPA/Arachidonic Acid (AA) ratio was assessed due
to its role in cognitive dysfunction and neuroinflammation (Rao
et al., 2007; Labrousse et al., 2012). EPA and DHA, but not
DPA, levels increased in n-3 PUFA group in comparison to
NAÏVE and OLIVE OIL groups, as revealed by one-way ANOVAs
on EPA and DHA levels [EPA: F(2, 12) = 26.77, p < 0.0001;
Table 2 | Blood concentrations of amino acids and carnitines for each experimental group are indicated.
Amino acids concentrations NAÏVE OLIVE OIL n-3 PUFA
Proline 86.81±6.42 81.85±6.41 91.75± 13.28
Valine 79.68±5.86 100.56±2.13 86.24± 13.23
Leucine/Isoleucine/Hydroxyproline 132.01±9.76 130.61±14.02 137.12± 13.19
Ornithine 53.24±12.18 44.29±4.62 54.22± 13.17
Methionine 26.14±6.23 24.86±1.87 24.55± 2.19
Phenylalanine 40.94±3.29 44.73±2.04 42.79± 3.69
Arginine 90.05±4.46 77.80±0.85 89.65± 5.82
Citrulline 36.87±2.76 34.86±4.87 39.07± 7.00
Tyrosine 44.46±7.96 41.25±2.80 40.84± 3.59
Glycine 632.28±128.26 609.72±112.52 619.95± 67.96
Alanine 57.92±9.73 69.77±2.73 74.46± 8.89
Serine 7.35±0.74 9.48±1.36 8.29± 2.62
Threonine 27.41±4.98 26.54±2.39 28.38± 4.20
Asparagine 4.10±0.91 3.42±0.32 3.27± 0.60
Aspartate 4.99±0.36 4.75±0.61 6.40± 0.51
Lysine/Glicine 1592.42±285.89 1583.62±200.26 1710.13± 136.14
Glutamate 34.97±3.25 35.51±1.57 31.40± 1.59
Histidine 52.12±3.69 53.23±1.10 54.65± 4.99
Carnitines concentrations
Carnitine free 14.62±2.05 17.97±1.11 15.31± 1.98
Acetylcarnitine* 15.32±1.38 17.02±1.24 22.76± 2.19
Propionylcarnitine 0.86±0.08 1.05±0.07 0.92± 0.08
Butyrylcarnitine 0.15±0.01 0.11±0.03 0.12± 0.03
Iovalerylcarnitine 0.06±0.01 0.07±0.01 0.09± 0.01
3-Hydroxybutyrylcarnitine/Malonylcarnitine 0.13±0.02 0.15±0.01 0.23± 0.07
3-Hydroxyisovalerylcarnitine/Methylmalonylcarnitine 0.13±0.03 0.15±0.01 0.16± 0.01
Glutarylcarnitine/3-Hydroxyhexanoylcarnitine 0.22±0.02 0.2±0.03 0.23± 0.02
Adipylcarnitine 0.09±0.02 0.09±0.01 0.11± 0.01
Tetradecenoylcarnitine 0.06±0.01 0.07±0.01 0.09± 0.03
Myristoylcarnitine 0.17±0.03 0.14±0.01 0.17± 0.03
Hexadecenoylcarnitine 0.13±0.02 0.12±0.01 0.15± 0.04
Palmitoylcarnitine 1.09±0.07 1.08±0.04 1.19± 0.07
Linoleylcarnitine 0.08±0.01 0.08±0.01 0.08± 0.01
Oleylcarnitine 0.42±0.02 0.49±0.02 0.50± 0.08
Stearoylcarnitine 0.21±0.01 0.22±0.01 0.24± 0.01
Values represent mean ± s.e.m. *p < 0.05.
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FIGURE 6 | n-3 PUFA effects on metabolic correlates. (A) Average blood
levels of acetylcarnitine (ALC) for the three experimental groups. (B) EPA
brain levels. (C) DHA brain levels. (D) EPA+DHA+DPA/AA ratio. ∗p < 0.05,
or ∗∗∗p < 0.001.
DHA: F(2, 12) = 6.21, p = 0.01; DPA: F(2, 12) = 1.85, p = 0.20].
Post-hoc comparisons indicated that n-3 PUFA mice exhibited
higher EPA (n-3 PUFA vs. NAÏVE p = 0.0001; n-3 PUFA vs.
OLIVE OIL p < 0.0001) and DHA (n-3 PUFA vs. NAÏVE p =
0.04; n-3 PUFA vs. OLIVE OIL p = 0.02) levels (Figures 6B,C).
No significant differences were found by comparing data of
NAÏVE and OLIVE OIL mice. Moreover, One-Way ANOVA on
the EPA+DHA+DPA/AA ratio revealed significant differences
among groups [F(2, 12) = 17.54, p = 0.0003]. Post-hoc compar-
isons indicated a significant increase of EPA+DHA+DPA/AA
ratio in n-3 PUFA group in comparison to NAÏVE (p = 0.0005)
and OLIVE OIL (p = 0.001) groups (Figure 6D).
DISCUSSION
The present data consistently demonstrate the beneficial effects of
n-3 PUFA supplementation on hippocampal resilience to aging.
In particular, our study indicates that a mixture of n-3 PUFA
containing EPA, DHA, and DPAmay improve hippocampal func-
tioning in C57B/6 aged mice. Interestingly, n-3 PUFA group
exhibited improved performances in all tasks tapping hippocam-
pal functions, as recognition memory (ORT), spatial perfor-
mances (SYM, MWM), and aversive responses (CFC), without
differences in anxiety levels (EPM) in comparison to OLIVE OIL
and NAÏVE groups. The marked improvement of hippocampal
cognitive functions occurred in the context of an enhanced cellu-
lar plasticity. In fact, n-3 PUFA noticeably increased neurogenesis,
dendritic arborization of DG newborn neurons, hippocampal
volumes and cell density. These findings, well corroborated by
the decrease in apoptosis, astrocytosis and lipofuscin deposits
as well as the increase in microglial cells observed in n-3 PUFA
group, demonstrate the specific neuroprotective effects of n-3
PUFA on hippocampal circuits. In accordance with the statement
by Kempermann et al. (2002), n-3 PUFA group’s hippocampus
has thus to be considered as healthier for a general decrease
in neurodegeneration (lipofuscin deposits, astroglia reactivity,
caspase-3+ cells) and an increase in regeneration (neurogenesis)
and clearance (microglial cells). Importantly, also the increased
levels of metabolic correlates (blood ALC, cerebral n-3 PUFA) of
n-3 PUFA treated mice point toward an effective neuroprotective
action of these fatty acids. Furthermore, we demonstrated that
the signs of neuronal aging can be diminished by enhancing n-3
PUFA intake, even when the supplementation starts at late age.
Thus, this category of fatty acids exerts not only an acute but also
a sustained effect on brain plasticity.
An interesting distinctive feature of the present study is the use
of commonly available supplements, as the easy-to-buy n-3 PUFA
mixture and frequently used olive oil. This accounts for the eco-
logical validity of the present results increasing their possibility of
generalization.
A further strength point of this research is the analysis in
the same aged animals of hippocampal mnesic functions, neu-
rogenic and glial responses, volumetric changes, and metabolic
correlates. Our findings expand those of the few animal studies
addressing n-3 PUFA effects on cognitive functions during aging.
Namely, it has been reported that EPA, DPA and/or DHA sup-
plementation delays cognitive decline in n-3 PUFA deficient aged
animals (Gamoh et al., 2001; Carrié et al., 2002), in senescence-
accelerated prone 8 mice (Petursdottir et al., 2008) and in aged
rodents (Jiang et al., 2009; Kelly et al., 2011; Labrousse et al.,
2012). The present behavioral data nicely fit also with the few
studies demonstrating the n-3 PUFA efficacy on slowing cogni-
tive decline in older people (Danthiir et al., 2011). However, this
is the first research associating behavioral, neurochemical and
neurogenic aspects in the general framework of the hippocam-
pal functionality in the presence of n-3 PUFA supplementation
during aging. Moreover, in the present study we report for the
first time n-3 PUFA enhancing effects on dendritic length and
branching complexity of newborn DG neurons. Interestingly,
along with substantial improvements in behavioral performance,
in n-3 PUFA group the proliferation rate of newly-generated
DG cells was potentiated with a number of newborn neurons
markedly higher than the control groups. Furthermore, the n-
3 PUFA supplementation stimulated neuroblasts differentiation
leading to major dendritic length and branching complexity of
newborn DG neurons. These observations fully fit with reversal
of decreased neurogenesis induced by n-3 PUFA treatment even
at old age (Dyall et al., 2007, 2010) and also with the neurite
enhancement (neuritogenesis) described in dorsal root ganglia of
EPA or DHA supplemented aged rats (Robson et al., 2010). The
mechanisms of the n-3 PUFA neurogenic action have still not
been conclusively described. n-3 PUFA supplementation might
increase the neuronal differentiation and neuritogenesis through
a reduction of inflammation. Such an anti-inflammatory activity
could be exerted by a metabolization of n-3 PUFA to neuropro-
tective mediators, such as neuroprotectin D1. Furthermore, n-3
PUFA might increase the signaling factors involved in neuroge-
nesis, such as BDNF, CREB, or CaMKII (Maruszak et al., 2014),
and the expression of genes involved in neurogenesis and neuri-
togenesis regulated at the transcriptional level (Dyall et al., 2010).
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Finally, n-3 PUFA might exert their bioactivity even through syn-
taxin 3 that mediates membrane expansion at the growth cone
given rise to neurite outgrowth (He et al., 2009).
An important aspect of the increased n-3 PUFA-induced
neurogenesis was its occurrence on the background of signs
of decreased neurodegeneration, as indicated by the increased
microglial phagocytosis and decreased astrocytosis and lipofuscin
deposits. In fact, the recent focus on the interdependent pro-
cesses linking microglia and neurogenesis evidenced, not only
the microglia role in phagocytosing apoptotic cells, but also their
ability in secreting factors that influence proliferation, differenti-
ation, and survival of newborn cells, either by a direct instructive
role or through secretion of neurotrophic factors (Gemma and
Bachstetter, 2013). Interestingly, n-3 PUFA, and mainly DHA,
increase the level of BDNF, which is predominantly synthesized
by hippocampal neurons (Jiang et al., 2009). BDNF can activate
synaptic proteins, such as synapsin-1 that increases the synthesis
of synaptic membranes, and leads to elevated levels of phos-
phatides and specific pre- and post-synaptic proteins. Via this
pathway n-3 PUFA increase the number of dendritic spines and
possibly synapses on hippocampal neurons, particularly the exci-
tatory glutamatergic synapses involved in learning and memory
(Janssen and Kiliaan, 2014).
Despite the vast literature on n-3 PUFA effects on brain struc-
ture and function, lipofuscin load has never been studied in n-3
PUFA supplemented subjects. The reduced lipofuscin deposits
exhibited by n-3 PUFA group in the whole hippocampus indi-
cated a decreased age-dependent degeneration, likely concurring
to the sustained (even at old age) induction of neurogenesis by n-
3 PUFA dietary enrichment. Analogously, caloric restriction, with
its robust effects on longevity, potentiates hippocampal neuro-
genesis and reduces lipofuscin load (Moore et al., 1995; Szweda
et al., 2003).
The diffuse astrocytosis occurring with age was markedly
reduced in n-3 PUFA group, indicating that an efficient astroglial
function should be maintained to prevent brain aging. Given
the high DHA concentrations in their membranes, astrocytes are
optimal targets of n-3 PUFA action in the brain. Interestingly,
n-3 PUFA deficiency worsens age-induced hippocampal astrocy-
tosis and promotes neuroinflammation (Layé, 2010; Latour et al.,
2013). On such a basis the reduction of astroglia reactivity by
n-3 PUFA supplementation demonstrated here could lead to a
reduction of pro-inflammatory cytokines.
Even if the restored neurogenesis could be related to the
increased hippocampal volumes of n-3 PUFA group, such a fac-
tor, as far as markedly significant, does not appear to be enough
to explain the whole hippocampal volumetric increase. In fact, the
neurogenic proliferation is a specific prerogative of dentate gyrus,
while the volumetric enlargement was found in all hippocam-
pal subfields. The enhanced hippocampal volume may rather be
related to a prevented neuronal loss linked to the n-3 PUFA neu-
roprotective properties. This hypothesis takes into account the
reduction in apoptosis, glial degeneration and oxidative stress,
and the parallel increase in neuronal and microglial density
observed in the n-3 PUFA group. Many studies highlighted n-3
PUFA efficacy in preventing hippocampal neuronal loss in AD-
like neurodegenerative models (Su, 2010; Hooijmans et al., 2012;
Denis et al., 2013; Luchtman and Song, 2013). In addition, the
few human studies addressing the relations between n-3 PUFA
intake and brain volumes converge on detrimental effects of n-3
PUFA deficiency and beneficial effects of their presence. Namely,
in recurrent affective disorders, including unipolar and bipolar
depression, the n-3 PUFA deficiency is associated with reduction
of the gray matter volume in the prefrontal cortex inducing in
turn alterations in cortico-limbic projections (McNamara, 2010).
Conversely, a positive association between n-3 PUFA intake and
gray matter volumes in hippocampus, amygdala and anterior cin-
gulate cortex were found in healthy subjects (Conklin et al., 2007).
More recently, EPA and DHA intake resulted positively correlated
with gray and white matter volumes and cognitive performances
in elderly subjects (Titova et al., 2013; Virtanen et al., 2013).
Ultimately, howmay themorphological changes here observed
be linked to the significant behavioral improvements induced by
n-3 PUFA supplementation? The increase of hippocampal neu-
ronal density induced by n-3 PUFA may be at least in part related
to the increase of phagocytic microglial cells and to the concomi-
tant reduction of astrogliosis, which in turn may favor the cellular
homeostasis and the hippocampal functionality within the aged
brain, thus finally improving mnesic abilities. Indeed, it has been
shown that aging is associated with senescence, reduced self-
renewal and impaired clearance functions of microglia, resulting
in a progressive impairment of the brain cellular processes (Streit,
2006; Sierra et al., 2007).
Neurogenesis is required for some types of learning and mem-
ory, and its rate decreases during aging in humans, non-human
primates, and rodents (Maruszak et al., 2014). Microglia are
essential component of the neurogenic niche in the DG of the
adult hippocampus (Gemma and Bachstetter, 2013) and have
an important function in phagocytosis of apoptotic cells during
the first days of their life. Thus, they provide an essential prun-
ing allowing a more efficient differentiation and integration of
newborn neurons into the existing circuits (Sierra et al., 2010).
On such a basis, we hypothesize that the increase of microglia
may concur to the increment of neurogenesis observed in the n-3
PUFA group (Figure 7).
Also with regards to metabolic findings we observed increased
EPA and DHA brain levels and EPA+DHA+DPA/AA ratio in n-3
PUFA group, in line with Gamoh et al. (2001) and Labrousse et al.
(2012). As known, EPA, DPA and especially DHA are key blocks
for brain cell membrane synthesis and properties, including flu-
idity, flexibility, permeability and neurotransmission regulation
(Crupi et al., 2013). Moreover, in the brain DHA and AA are
continuously released from membrane phospholipids and create
a constant turn-over of PUFA between brain and plasma to be
daily balanced by the diet (Luchtman and Song, 2013). The n-3:n-
6 PUFA ratio is important for essential neurobiological functions
like neurotransmission, as well as for the equilibrium of the bioac-
tive metabolites produced from n-3 PUFA that are involved in the
oxidative stress and inflammatory response (Denis et al., 2013).
Interestingly, the relative lack of n-3 PUFA featuring the Western
diet results in a chronic n-3 PUFA deficit in brain membranes
and overproduction of AA derivatives that favor the emergence of
the a pro-inflammatory status characteristic of brain aging (Denis
et al., 2013). On such a basis, we hypothesize that the increase of
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FIGURE 7 | Schematic representation of the cellular mechanisms underlying the beneficial effects of n-3 PUFA supplementation on
hippocampal-dependent mnesic functions in aged mice.
EPA+DHA+DPA/AA ratio observed in the brain of n-3 PUFA
group results in a reduction of the oxidative stress and inflam-
matory responses and in an enhancement of neurotransmission
that in turn contribute in retaining better mnesic performances
(Figure 7).
Finally, it has to be taken into account that the ameliorated
mnesic performances of n-3 PUFA group were associated to high
ALC blood levels, without differences in the other carnitines and
amino acids analyzed. Crossing the blood-brain barrier, ALC
shuttles acetyl groups and fatty acids into brain cell mitochondria
for energy production and acts as direct anti-oxidant (Kobayashi
et al., 2010; Goo et al., 2012). Remarkably, ALC improves cog-
nitive deficits in aged or demented human subjects (Ames and
Liu, 2004; Mancuso et al., 2007; Glade, 2010; Malaguarnera,
2012). Preclinical studies indicate that ALC counteracts cognitive
decline even in the presence of β-amyloid toxicity (Kaur et al.,
2001; Dhitavat et al., 2005; Abdul et al., 2006; Barhwal et al.,
2009; Suchy et al., 2009). Moreover, ALC improves mnesic capac-
ities, restores serum, heart, muscle and brain carnitine levels,
and improves the cholinergic neurotransmission dysregulated by
aging (Kobayashi et al., 2010). Notably, in animal studies also n-3
PUFA dietary supplementation improves cholinergic transmis-
sion in the brain (Willis et al., 2009). Moreover, additive effects
of ALC and PUFA supplementation in reducing age-related reti-
nal degeneration (Feher et al., 2005) and brain damages caused
by oxidative stress (Liu et al., 2002) have been reported. Thus, our
findings indicating enhanced ALC levels following n-3 PUFA sup-
plementation not only support the ALC neuroprotective efficacy,
but for the first time demonstrate that an enhanced n-3 PUFA
intake is able to increase ALC levels. This intriguing association
may lead to the described cognitive improvement by improving
mitochondrial functions and reducing oxidative stress but likely
even by enhancing cholinergic transmission (Figure 7).
In conclusion, our study suggests that n-3 PUFA are able to get
an aged hippocampus to be “younger” and more functional by
multiple mechanisms, as summarized in Figure 7. Consequently,
n-3 PUFA appear ideal candidates for cognition-enhancing nutri-
tional interventions aimed to promote successful and healthy
aging. This issue is of growing relevance, given the pressing ques-
tion of how the elderly can maintain their cognitive functions
in the Western population whose life expectancy increasingly
raises.
Future studies investigating the cellular and molecular mecha-
nisms through which PUFA supplementation acts will be useful
for understanding its functional significance in counteracting
brain aging.
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